Skip to main content
. 2016 Oct 6;160(2):305–312. doi: 10.1007/s10549-016-4001-y

Fig. 1.

Fig. 1

Schematic of randomized discontinuation trial (RDT) design. ER estrogen receptor, CR complete response, PD progressive disease, PR partial response, SD stable disease